IFN-γ has been shown to selectively eradicate label-preserving cancer cells (LRCC), a group of stem-like cancer cells that exhibit slow proliferation, enhanced chemical resistance, and tumor-initiation (119). This evidence concerns the gene IFNG and cancer.